US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (255)
  • Diseases & Conditions (4037)
  • Drug Delivery (285)
  • Therapeutic Area (7265)
  • Vaccines (721)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 6th Edition
7/16/2014 | published by: Kalorama Information
... with base year data for 2014, Clinical Nutrition Products: A Worldwide Perspective is a Kalorama Information report that focuses on three primary segments of essential medical nutrition: Infant Nutrition (Milk-based, Soy-based, Elemental, Follow-Up, Organic, Probiotic ...  |  read more...
USD 3,995
Botulism - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Botulism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Kidney Fibrosis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Kidney Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Relapsed Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Liver Failure - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Liver Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Lymphangioleiomyomatosis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Lymphangioleiomyomatosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Chronic Pain - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Chronic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
AngioGenex, Inc. - Product Pipeline Review - 2014
7/31/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of AngioGenex, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
PharmEste - Product Pipeline Review - 2014
7/31/2014 | published by: Global Markets Direct
... on the current therapeutic developmental pipeline of PharmEste’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest ...  |  read more...
USD 1,500
SanBio, Inc. - Product Pipeline Review - 2014
7/31/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of SanBio, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Laboratorios Sophia S.A. de C.V. - Product Pipeline Review - 2014
7/31/2014 | published by: Global Markets Direct
... de C.V.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Sophia S.A. de C.V.’s, complete with comparative analysis at various stages, therapeutics assessment by drug ...  |  read more...
USD 1,500
Amplyx Pharmaceuticals, Inc. - Product Pipeline Review - 2014
7/31/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Amplyx Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Proteologics Ltd. - Product Pipeline Review - 2014
7/31/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Proteologics Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Targazyme, Inc. - Product Pipeline Review - 2014
7/31/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Targazyme, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Neuromyelitis Optica (Devic’s Syndrome) Global Clinical Trials Review, H2, 2014
7/28/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Neuromyelitis Optica (Devic’s Syndrome). It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Radius Health, Inc. - Product Pipeline Review - 2014
8/14/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Radius Health, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Kazakhstan : Pharmaceuticals and Healthcare Report Q3 2014
8/6/2014 | published by: Business Monitor International
... sales of the market, as thegovernment makes more progress in its efforts to widen the country's currently limited coverage. TheKazakh government's continued commitment to increasing expenditure on healthcare along with risinglocal wages will drive growth ...  |  read more...
USD 1,295
Mauritius : Pharmaceuticals and Healthcare Report Q3 2014
8/6/2014 | published by: Business Monitor International
... growth will be slowdue to the limited capacity of local drugmakers. Headline Expenditure Projections Pharmaceuticals: MUR6.00bn (USD195mn) in 2013 to MUR6.56bn (USD220mn) in 2014; 9.35% growthin local currency terms. Healthcare: MUR17.44bn (USD567mn) in 2013 to ...  |  read more...
USD 1,295
Global Hodgkins Lymphoma Therapeutics Market : 2014-2018
8/6/2014 | published by: TechNavio - Infiniti Research Ltd.
... Commenting on the report, an analyst from TechNavio’s team said: “There has been an increase in awareness of Hodgkin's lymphoma among patients and physicians. Enhanced patient and physician awareness is expected to lead to earlier ...  |  read more...
USD 2,500
Global Lysosomal Storage Diseases Market : 2014-2018
7/30/2014 | published by: TechNavio - Infiniti Research Ltd.
... Ltd., BioMarin Pharmaceutical Inc., Genzyme Corp. and Shire plc. Other Prominent Vendors in the market are: Mylan, Pfizer, Protalix, Raptor, Recordati, Sigma-Tau Commenting on the report, an analyst from TechNavio’s team said: “One of the ...  |  read more...
USD 2,500
Essential Thrombocythemia - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Essential Thrombocythemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Medulloblastoma - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Medulloblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Renal Pain Global Clinical Trials Review, H2, 2014
7/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Renal Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Northern Antibiotics Oy - Product Pipeline Review - 2014
8/14/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Northern Antibiotics Oy’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
< prev 1    3  4  5  6  7  8  9  10